Amendment Number Thirteen to Amended and Restated Non-Exclusive Distribution Agreement, dated June 1, 2023, by and between DexCom, Inc. and Byram Healthcare
Contract Categories:
Business Operations
- Distribution Agreements
EX-10.05 5 dxcm6302023ex1005-byramhea.htm EX-10.05 Document
Exhibit 10.05
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [******], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.
AMENDMENT NUMBER THIRTEEN
TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT
This AMENDMENT NUMBER THIRTEEN TO THE AMENDED AND RESTATED NON-EXCLUSIVE DISTRIBUTION AGREEMENT (“Amendment”) is made effective as of June 1, 2023 (“Amendment Effective Date”) by and between DexCom, Inc. (“DexCom”) and Byram Healthcare (“Distributor”). Capitalized terms used herein but not defined shall have the meaning ascribed to them in the Agreement.
RECITALS
WHEREAS, DexCom and Distributor previously entered into that certain Amended and Restated Non-Exclusive Distribution Agreement entered into by the Parties as of February 1, 2016 (as the same has been and may be amended from time to time, the “Agreement”); and
WHEREAS, DexCom and Distributor desire to further amend the Agreement, as more fully described herein.
AGREEMENT
NOW THEREFORE, DexCom and Distributor agree as follows:
1.Schedule 1, The Products and The Prices.
a.Schedule 1 of the Agreement is hereby deleted and replaced in its entirety and is updated to include the changes to [******] Rebates and their associated terms listed therein.
2.No Further Modification. Except to the extent set forth in this Amendment, all other terms and conditions of the Agreement shall remain unmodified and in full force and effect.
[Remainder of Page Intentionally Blank;
Signature Page Follows]
Signature Page Follows]
IN WITNESS WHEREOF, the parties have executed this Amendment effective as of the Amendment Effective Date.
| DexCom, Inc. | Distributor | |||||||||||||
| By: | /s/ Christophe Cantenot | By: | /s/ Neel Vadhan | |||||||||||
| Name: | Christophe Cantenot | Name: | Neel Vadhan | |||||||||||
| Title: | VP, Finance and Corporate Controller | Title: | VP, Purchasing | |||||||||||
| Date: | 4/25/2023 | Date: | 4/20/2023 | |||||||||||
SCHEDULE 1
The Products and The Prices
[******]
